Annals of Oncology · 2009 · 165 citations · 21 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMedical OncologyCombination ChemotherapyCytotoxic ChemotherapyMtor Inhibitor TherapyEgfr InhibitionEverolimus PharmacokineticsEverolimus TreatmentEverolimus-based RegimensMtor Inhibition
21
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text
Medicine, Oncology, Pharmacology +15
Optimal two-stage designs for phase II clinical trials
Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations